Overcoming Challenges of TGF-β Targeted Therapies by Selecting Suitable Combinations to Achieve Clinical Success

Time: 12:30 pm
day: Conference Day One


  • Investigating different potential checkpoint inhibitors (SMAD, PD1) with TGF-β targetedtherapies for the most effective patient response
  • Advancing to the next level by using proven combination TGF-β directed therapies to show clinical efficacy
  • Employing a multi-pronged method to turn tumors from cold to hot